Sharon Bio-Medicine has informed that the Board of Directors of the company at its meeting held on June 10, 2014, have approved issue of upto 1,80,00,000 warrants, convertible into equity shares to Promoter Croup at a price to be calculated as per SEBI ICDR regulations, subject to a minimum price of Rs. 45 per warrant/ share [Rs. 2 towards face value and balance towards premium), subject to the consent of the Members of the company to be obtained through Postal Ballot. Board approved the Postal Ballot notice to be sent to the Members.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1669.30 |
| Dr. Reddys Lab | 1234.00 |
| Cipla | 1231.50 |
| Zydus Lifesciences | 937.50 |
| Lupin | 2329.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: